Weekly ReportJul 27, 2025
Anesthesiology, week 30 edition
We read 3 papers and selected 3.
Summary
This week produced influential mechanistic and clinical studies that reshape perioperative neuroimmunology, regional anesthesia choices, and individualized ventilation. A preclinical spinal neuroimmune study implicates spinal astrocyte α2A-adrenergic signaling (and dexmedetomidine) in protecting the heart during sepsis. High-quality RCT evidence favors paravertebral over erector spinae plane block for major breast surgery analgesia, and physiologic and RCT work advances precision ventilation (esophageal pressure and R/I) and intraoperative respiratory strategies.
Selected Articles
1. Activation of Spinal Astrocyte α2A Adrenoceptors Protects Against Sepsis-Induced Heart Injury Through Inhibition of GABAergic Neuronal Necroptosis.
In a CLP sepsis model, spinal GABAergic neuronal necroptosis mediated cardiac dysfunction; necroptosis inhibition preserved neurons and cardiac function. Dexmedetomidine acting on spinal α2A-ARs suppressed astrocyte inflammatory signaling (C3, IL-6, TNF-α), reduced neuronal injury, and prevented sepsis-associated cardiomyopathy, suggesting a spinal neuroimmune mechanism amenable to pharmacologic modulation.
Impact: Identifies a mechanistic spinal neuroimmune pathway linking sepsis to cardiac dysfunction and repurposes an existing sedative (dexmedetomidine) as a candidate modulator — high translational potential for preventing organ dysfunction in sepsis.
Clinical Implications: Provides mechanistic justification to prioritize clinical evaluation of dexmedetomidine regimens (timing, dose, route) for mitigating sepsis-associated cardiomyopathy and to develop biomarkers for patient selection in early-phase trials.
Key Findings
- CLP-induced sepsis produced spinal GABAergic neuronal necroptosis with upregulation of RIPK1/RIPK3/MLKL and reduced cardiac function.
- Necroptosis inhibitor (Necrostatin-1) preserved spinal neurons and reversed cardiac dysfunction.
- Dexmedetomidine activation of spinal α2A-ARs reduced astrocyte C3/IL-6/TNF-α, neuronal injury, and prevented cardiomyopathy.
2. Erector spinae plane block versus paravertebral block for major oncological breast surgery: a multicentre randomised controlled trial.
Prospective multicenter double-blind RCT (n=292) comparing ESPB vs thoracic PVB for major breast cancer surgery found ESPB failed noninferiority for early morphine rescue (75.2% vs 50.3% requiring morphine within 2 h). ESPB produced higher pain scores (notably on mobilization) and less reliable dermatomal coverage, while morphine consumption and satisfaction were similar and no major complications occurred.
Impact: High-quality RCT directly informs regional anesthesia selection for breast cancer surgery and challenges routine adoption of ESPB as a primary technique.
Clinical Implications: When feasible and expertise allows, thoracic paravertebral block should remain the preferred regional technique for major oncological breast surgery; ESPB may be reserved when PVB contraindicated or infeasible, with counseling about potentially higher early pain and incomplete dermatomal coverage.
Key Findings
- ESPB did not meet noninferiority for need for morphine within 2 h (75.2% ESPB vs 50.3% PVB).
- ESPB had higher pain scores during mobilization and more frequent incomplete dermatomal coverage (55.9% vs 20.4%).
- No major complications; morphine consumption and patient satisfaction were similar between groups.
3. Role of Supramammillary Nucleus Glutamatergic Neurons in Modulating Consciousness Transitions during Propofol Anesthesia in Mice.
Using fiber photometry, chemogenetics, and optogenetics in mice, the study shows SuM glutamatergic neuron activity falls before propofol-induced loss of consciousness and surges at recovery. Bidirectional manipulation altered induction and emergence times, and SuM or SuM→medial septum stimulation evoked arousal and cortical activation during maintenance, identifying a circuit-level arousal node.
Impact: Defines a discrete arousal circuit (SuM→MS) that can reverse anesthetic-induced unconsciousness in animals, providing a mechanistic target to modulate emergence and refine anesthetic monitoring.
Clinical Implications: Preclinical evidence suggests potential neuromodulatory strategies to hasten emergence or treat delayed awakening; motivates translational work to identify biomarkers of SuM engagement and test targeted stimulation in larger models and, eventually, humans.
Key Findings
- SuM glutamatergic neuronal activity decreases before loss of consciousness and increases at recovery under propofol.
- Chemogenetic ablation shortened induction and prolonged recovery; activation had opposite effects.
- Optogenetic stimulation of SuM or SuM→medial septum induced arousal and cortical activation during maintenance anesthesia.